A White House summit on nutrition and health to be held later this month will consider whether to mandate that nutritional information be made available on the front panel of food and beverage packages.
Public health advocates are pushing for such a mandate, but industry groups are opposing it.
Decisions will be made on whether such a system should be mandatory or voluntary, what types of information to include, and how strongly to make any warnings about harmful components.
Democrats have proposed legislation requiring mandatory front-of-package labeling.
Sen. Richard Blumenthal (D-Conn.) justified the plan saying people don’t have the patience or the time to be detectives on store shelves, hunting for data that may be somewhere on the package.
In 2011, the Consumer Brands Association assisted in the launch of Facts Up Front, a voluntary front-of-package information program. However, the organization is opposed to any mandatory programs. Critics accuse voluntary programs like Facts Up Front of being whitewashed.
Five countries now require nutritional information on the front of the packaging. According to a recent study of Chilean consumers, the market share for breakfast cereals with calorie and sugar warnings decreased slightly but significantly. Furthermore, some manufacturers began reformulating their products to fall below the warning thresholds.


Asian Stocks Rebound as Trump Delays Iran Strike Deadline
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
FEMA Reinstates $1 Billion Disaster Prevention Grant Program After Court Order
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Asian Currencies Stay Muted as Dollar Holds Firm Amid Iran Uncertainty
NAB Plans to Cut 170 Jobs While Expanding Offshore Operations
Gold is meant to be a ‘safe haven’ in uncertain times. Why is it crashing amid a war?
Nintendo Switch 2 Production Cut as Holiday Sales Miss Targets
WTO Reform Talks Begin in Cameroon Amid Global Trade Tensions
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Trump Administration Settles Lawsuit Barring Federal Agencies from Pressuring Social Media Censorship
France's 2025 Budget Deficit Shrinks More Than Expected, Easing Fiscal Pressure
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Oil Prices Slip as Trump Extends Iran Ceasefire Deadline Amid Ongoing War Fears 



